Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Bode

Showing results (491-500 of 600) with videos related to

Pageof 60
Sort By:
Journal of Cardiovascular Pharmacology|December 8, 2010
Pharmacological activation of Kv11.1 in transgenic long QT-1 rabbitsBo Hjorth Bentzen, Sophia Bahrke, Kezhong Wu, et al.
Plos One|May 5, 2011
Cannabinoid receptor 2 signaling does not modulate atherogenesis in miceFlorian Willecke, Katharina Zeschky, Alexandra Ortiz Rodriguez, et al.
Cells|December 24, 2021
P2Y<sub>12</sub> Inhibition in Murine Myocarditis Results in Reduced Platelet Infiltration and Preserved Ejection FractionSarah Nasreen Schmidt, Wilfried Reichardt, Beat A Kaufmann, et al.
Basic Research in Cardiology|May 13, 2015
SIRT3 deficiency impairs mitochondrial and contractile function in the heartChristoph Koentges, Katharina Pfeil, Tilman Schnick, et al.
The New England Journal of Medicine|September 8, 2006
Enoxaparin versus unfractionated heparin in elective percutaneous coronary interventionGilles Montalescot, Harvey D White, Richard Gallo, et al.
JACC. Cardiovascular Interventions|November 21, 2009
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention 1-year results from the STEEPLE (SafeTy and efficacy of enoxaparin in percutaneous coronary intervention patients, an international randomized evaluation) trialGilles Montalescot, Richard Gallo, Harvey D White, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 26, 2021
Catheter ablation of short-coupled variant of torsade de pointesJohannes Steinfurt, Babak Nazer, Martin Aguilar, et al.
Research and Practice in Thrombosis and Haemostasis|December 28, 2022
Early SARS-CoV-2 infection: Platelet-neutrophil complexes and platelet functionMarina Rieder, Niklas Baldus, Daniela Stallmann, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 21, 2019
Residual inflammatory risk in coronary heart disease: incidence of elevated high-sensitive CRP in a real-world cohortAlexander Peikert, Klaus Kaier, Julian Merz, et al.
Circulation. Cardiovascular Interventions|January 12, 2021
Sex Differences in Ischemic and Bleeding Outcomes in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Insights From the TAO TrialJean-Guillaume Dillinger, Gregory Ducrocq, Yedid Elbez, et al.
Pageof 60

Showing results (491-500 of 600) with videos related to

Sort By:
Pageof 60
Journal of Cardiovascular Pharmacology|December 8, 2010
Pharmacological activation of Kv11.1 in transgenic long QT-1 rabbitsBo Hjorth Bentzen, Sophia Bahrke, Kezhong Wu, et al.
Plos One|May 5, 2011
Cannabinoid receptor 2 signaling does not modulate atherogenesis in miceFlorian Willecke, Katharina Zeschky, Alexandra Ortiz Rodriguez, et al.
Cells|December 24, 2021
P2Y<sub>12</sub> Inhibition in Murine Myocarditis Results in Reduced Platelet Infiltration and Preserved Ejection FractionSarah Nasreen Schmidt, Wilfried Reichardt, Beat A Kaufmann, et al.
Basic Research in Cardiology|May 13, 2015
SIRT3 deficiency impairs mitochondrial and contractile function in the heartChristoph Koentges, Katharina Pfeil, Tilman Schnick, et al.
The New England Journal of Medicine|September 8, 2006
Enoxaparin versus unfractionated heparin in elective percutaneous coronary interventionGilles Montalescot, Harvey D White, Richard Gallo, et al.
JACC. Cardiovascular Interventions|November 21, 2009
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention 1-year results from the STEEPLE (SafeTy and efficacy of enoxaparin in percutaneous coronary intervention patients, an international randomized evaluation) trialGilles Montalescot, Richard Gallo, Harvey D White, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|March 26, 2021
Catheter ablation of short-coupled variant of torsade de pointesJohannes Steinfurt, Babak Nazer, Martin Aguilar, et al.
Research and Practice in Thrombosis and Haemostasis|December 28, 2022
Early SARS-CoV-2 infection: Platelet-neutrophil complexes and platelet functionMarina Rieder, Niklas Baldus, Daniela Stallmann, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 21, 2019
Residual inflammatory risk in coronary heart disease: incidence of elevated high-sensitive CRP in a real-world cohortAlexander Peikert, Klaus Kaier, Julian Merz, et al.
Circulation. Cardiovascular Interventions|January 12, 2021
Sex Differences in Ischemic and Bleeding Outcomes in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Insights From the TAO TrialJean-Guillaume Dillinger, Gregory Ducrocq, Yedid Elbez, et al.
Pageof 60